UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?

Stocks Zacks Investment Research By Zacks Investment Research 13 Oct 2026 23:30 1 min read

UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings? Zacks Investment Research

Covered in this story

Johnson & Johnson JNJ$248.61-5.73% UnitedHealth Group UNH$377.76-0.20%

Analyst targets on Johnson & Johnson

RBC Capital Markets: $255 → $290 by Oct 2027 · Outperform via Investing.com
Bank of America: $265 → $278 by Sep 2027 · Neutral via AOL.com
UBS: $275 → $320 by Sep 2027 · Buy via Investing.com

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $JNJ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Johnson & Johnson →

Dalsna Finance is currently tracking 45 stories mentioning Johnson & Johnson, the earliest published 31 Aug 2026.

Read the full story on Zacks Investment Research → Opens the original article on news.google.com

Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.